BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11064897)

  • 1. [Symptom scores: what do they describe exactly?].
    Pupca G; Patard JJ; Ziadé J; Guiraud P; Lobel B; Guillé F
    Prog Urol; 2000 Sep; 10(4):561-7. PubMed ID: 11064897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. ALFECH Study Group.
    Hansen BJ; Mortensen S; Mensink HJ; Flyger H; Riehmann M; Hendolin N; Nordling J; Hald T
    Br J Urol; 1998 Jan; 81(1):36-41. PubMed ID: 9467474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a new treatment outcome score for men with LUTS.
    Weiss JP; Blaivas JG; Tash Anger JA; Di Blasio CJ; Panagopoulos G; Gerboc J
    Neurourol Urodyn; 2004; 23(2):88-93. PubMed ID: 14983416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lower urinary tract symptoms are poorly correlated with erectile dysfunction].
    Marionneau N; Perrin P; Taieb C
    Prog Urol; 2006 Nov; 16(5):572-7. PubMed ID: 17175954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the IPSS (International Prostate Symptoms Score) to evaluate the frequency of disability induced by each of the 7 symptoms. (CTMH-AFU study)].
    de la Taille A; Desgrandchamps F; Haillot O; Saussine C; Lukacs B; Marc F;
    Prog Urol; 2006 Nov; 16(5):568-71. PubMed ID: 17175953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A modified IPSS score: value of a choice of qualitative answers].
    Perrin P; Némoz C; Paparel P; Ruffion A
    Prog Urol; 2006 Apr; 16(2):168-73. PubMed ID: 16734240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between lower urinary tract symptoms frequency assessed by the IPSS and bothersomeness (SPI) among men older than 50 years old.
    Perrin P; Marionneau N; Cucherat M; Taieb C
    Eur Urol; 2005 Oct; 48(4):601-7. PubMed ID: 16055260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
    Shao Q; Song J; Guo YW; Lu WC; Du LD
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do reported micturition symptoms on the American Urological Association Questionnaire correlate with 24-hour home uroflowmetry recordings?
    Matzkin H; Greenstein A; Prager-Geller T; Sofer M; Braf Z
    J Urol; 1996 Jan; 155(1):197-9. PubMed ID: 7490832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
    Bozlu M; Ulusoy E; Cayan S; Akbay E; Görür S; Akbay E
    Scand J Urol Nephrol; 2004; 38(5):391-5. PubMed ID: 15764250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of the urinary status by self-administered questionnaires in men after radical prostatectomy-- comparison with the urination status of elderly women].
    Taoka R; Shimada O; Kitamura Y; Okazoe H; Taniguchi S; Tsunemori H; Wu X; Inui M; Sugimoto M; Kakehi Y
    Hinyokika Kiyo; 2008 Nov; 54(11):717-22. PubMed ID: 19068725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of the pediatric dysfunctional voiding symptom score in monitoring response to behavioral modification.
    Farhat W; McLorie GA; O'Reilly S; Khoury A; Bägli DJ
    Can J Urol; 2001 Dec; 8(6):1401-5. PubMed ID: 11788017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal changes in symptom score and uroflowmetry in patients with lower urinary tract symptoms.
    Watanabe T; Maruyama S; Maruyama Y; Kageyama S; Shinbo H; Otsuka A; Ozono S
    Scand J Urol Nephrol; 2007; 41(6):521-6. PubMed ID: 17853015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.
    Awa Y; Suzuki H; Hamano S; Okano T; Sakurayama Y; Ohki T; Egoshi K; Ota S; Mori I; Ichikawa T
    Int J Urol; 2008 Aug; 15(8):709-15. PubMed ID: 18662175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional voiding and incontinence scoring system: quantitative evaluation of incontinence symptoms in pediatric population.
    Akbal C; Genc Y; Burgu B; Ozden E; Tekgul S
    J Urol; 2005 Mar; 173(3):969-73. PubMed ID: 15711352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between lower urinary tract symptoms and erectile dysfunction.
    Aslan G; Cavus E; Karas H; Oner O; Duran F; Esen A
    Arch Androl; 2006; 52(3):155-62. PubMed ID: 16574595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy-related dysuria.
    Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Lief JH
    BJU Int; 2005 Mar; 95(4):597-602. PubMed ID: 15705087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality of life assessment of the male with benign prostate hypertrophy].
    Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
    Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.